Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, effectiveness, and tolerability of the
anti-HIV drugs efavirenz and lamivudine/zidovudine given to treatment-naive HIV infected
people in Wenxi County, Shanxi Province, China.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Efavirenz Lamivudine Lamivudine, zidovudine drug combination Zidovudine